Systemic Psoriasis Therapeutics - Global Market Trajectory & Analytics

Global Systemic Psoriasis Therapeutics Market to Reach $19.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Systemic Psoriasis Therapeutics estimated at US$10.7 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 8.6% over the period 2020-2027.



The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 8% CAGR

The Systemic Psoriasis Therapeutics market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

Select Competitors (Total 38 Featured):

• AbbVie Inc.
• Amgen Inc.
• Biogen Idec
• Celgene Corporation
• Eli Lilly and Company
• Janssen Biotech, Inc.
• Novartis AG
• Pfizer Inc.
• Stiefel Laboratories, Inc.
• Takeda Pharmaceutical Company Limited